December 2019 FDA Recall Drug by Jubilant Cadista Pharmaceuticals, Inc.
D-0576-2020 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Jubilant Cadista Pharmaceuticals, Inc. on December 2, 2019 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0576-2020

Reason for Recall
Presence of Foreign Substance: Presence of a foreign object in a single tablet.
Initiated
12-02-2019
Reported
12-18-2019
Quantity
1,824 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Jubilant Cadista Pharmaceuticals, Inc.
Nationwide in the USA.
Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.

Batch or Lot Expiration Information

Lot# : NT119005A, Exp 07/2021